Hedge Fund Patent Petitions Could Be Squashed
Executive Summary
Celgene now has permission to seek dismissal of Kyle Bass' challenge of a Thalomid patent.
You may also be interested in...
Payors Take Lead From FTC In Suing BI Over Its Orange Book Patent Listings For Inhalers
Class action complaint alleges Boehringer Ingelheim engaged in a ‘Respimat Orange Book scheme’ to thwart generic competition for Combivent Respimat and Spiriva Respimat that cost payors millions, if not billions, in overcharges.
IRA Litigation: NJ Judge Looks For Own Path In Evaluating Medicare Price Negotiation Program
During oral argument in four cases challenging the IRA, Judge Zahid Quraishi suggested he may find that Medicare participation is voluntary but takings claim would still need to be considered. On question of whether the program is hurting innovation, Quraishi seemed skeptical.
Who's Who In The IRA Court Drama
Pink Sheet offers a graphical guide to the lawyers behind the briefs and at the podiums for the big showdown in Trenton.